Innate Immunity clinical trials

Explore recruiting innate immunity clinical trials.

Recruiting innate immunity studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Innate Immunity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 4, open-label study to evaluate the short-term innate immune response after administration of a COVID-19 mRNA vaccine (Comirnaty JN.1®) in healthy adults aged 18 to 40 years.

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

A randomised, controlled, parallel group, open-label trial evaluating the impact of treatment with the GLP-1 analogue semaglutide on weight loss in people living with HIV and obesity (SWIFT Study)

Ireland, Denmark, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Innate Immunity trials by city

Innate Immunity in Toronto Innate Immunity in Vancouver Innate Immunity in Montreal Innate Immunity in Calgary Innate Immunity in Edmonton Innate Immunity in Ottawa Innate Immunity in Winnipeg Innate Immunity in Quebec City Innate Immunity in Hamilton Innate Immunity in Kitchener Innate Immunity in London Innate Immunity in Halifax Innate Immunity in New York Innate Immunity in Los Angeles Innate Immunity in Chicago Innate Immunity in Houston

Innate Immunity clinical trials

Recruiting innate immunity studies right now

The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes

Innate Immunity Stimulation Via TLR9 in Early AD

A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors

Vegetarian Diet and Innate Immunity in Patients With Myocardial Infarction and in Healthy Volunteers (FRESH-MI Study)

The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)

Also recruiting in Europe

A phase 4, open-label study to evaluate the short-term innate immune response after administration of a COVID-19 mRNA vaccine (Comirnaty JN.1®) in healthy adults aged 18 to 40 years.

A randomised, controlled, parallel group, open-label trial evaluating the impact of treatment with the GLP-1 analogue semaglutide on weight loss in people living with HIV and obesity (SWIFT Study)

Innate Immunity trials by city

Other conditions